Recombinant Dna Vaccines Market Report

China Recombinant Dna Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Oct 12, 2023
  • PAGES：178
  • REPORT CODE：GMM1846305
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Dna Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sanofi Pasteur SA (France)

    • Hualan Biological Engineering Inc (China)

    • MedImmune (US)

    • SK Chemicals Co, Ltd (Korea)

    • ALK - Abello A/S (Denmark)

    • Pfizer Inc (US)

    • BiondVax Pharmaceuticals Ltd (Israel)

    • Merck & Co, Inc (US)

    • Zydus Cadila (India)

    • Bharat Biotech International Limited (India)

    • Janssen Pharmaceuticals, Inc (US)

    • GlaxoSmithKline Plc (UK)

    • Takeda Pharmaceutical Company Limited (Japan)

    • Seqirus (UK)

    • Altimmune, Inc (US)

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Dna Vaccines Market Overview 2018-2029

    • 1.1 China Recombinant Dna Vaccines Industry Development Overview

    • 1.2 China Recombinant Dna Vaccines Industry Development History

    • 1.3 China Recombinant Dna Vaccines Industry Market Size (2018-2029)

    • 1.4 China Recombinant Dna Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Dna Vaccines Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Recombinant Dna Vaccines Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Recombinant Dna Vaccines Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Recombinant Dna Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Dna Vaccines Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Recombinant Dna Vaccines Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Recombinant Dna Vaccines Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Recombinant Dna Vaccines Market Analysis by Region

      • 1.6.1 North China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Dna Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Dna Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Dna Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Dna Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Dna Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Dna Vaccines Industry Development

    Chapter 3 Recombinant Dna VaccinesIndustry Chain Analysis

    • 3.1 Recombinant Dna Vaccines Industry Chain

    • 3.2 Recombinant Dna Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Dna Vaccines Market

    • 3.3 Recombinant Dna Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Dna Vaccines Market

    Chapter 4 China Recombinant Dna Vaccines Market, by Type

    • 4.1 China Recombinant Dna Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Dna Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Dna Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Dna Vaccines Production Volume and Growth Rate of Type 1

      • 4.5.2 China Recombinant Dna Vaccines Production Volume and Growth Rate of Type 2

      • 4.5.3 China Recombinant Dna Vaccines Production Volume and Growth Rate of Type 3

    Chapter 5 China Recombinant Dna Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Dna Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Dna Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Dna Vaccines Market Size and Growth Rate of Application 1

      • 5.5.2 China Recombinant Dna Vaccines Market Size and Growth Rate of Application 2

      • 5.5.3 China Recombinant Dna Vaccines Market Size and Growth Rate of Application 3

    Chapter 6 China Recombinant Dna Vaccines Market, by Region

    • 6.1 China Recombinant Dna Vaccines Production Volume and Production Value, by Region

    • 6.2 China Recombinant Dna Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Dna Vaccines Market Analysis

    • 7.1 North China Recombinant Dna Vaccines Market, by Type

    • 7.2 North China Recombinant Dna Vaccines Market, by Application

    Chapter 8 Central China Recombinant Dna Vaccines Market Analysis

    • 8.1 Central China Recombinant Dna Vaccines Market, by Type

    • 8.2 Central China Recombinant Dna Vaccines Market, by Application

    Chapter 9 South China Recombinant Dna Vaccines Market Analysis

    • 9.1 South China Recombinant Dna Vaccines Market, by Type

    • 9.2 South China Recombinant Dna Vaccines Market, by Application

    Chapter 10 East China Recombinant Dna Vaccines Market Analysis

    • 10.1 East China Recombinant Dna Vaccines Market, by Type

    • 10.2 East China Recombinant Dna Vaccines Market, by Application

    Chapter 11 Northeast China Recombinant Dna Vaccines Market Analysis

    • 11.1 Northeast China Recombinant Dna Vaccines Market, by Type

    • 11.2 Northeast China Recombinant Dna Vaccines Market, by Application

    Chapter 12 Southwest China Recombinant Dna Vaccines Market Analysis

    • 12.1 Southwest China Recombinant Dna Vaccines Market, by Type

    • 12.2 Southwest China Recombinant Dna Vaccines Market, by Application

    Chapter 13 Northwest China Recombinant Dna Vaccines Market Analysis

    • 13.1 Northwest China Recombinant Dna Vaccines Market, by Type

    • 13.2 Northwest China Recombinant Dna Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sanofi Pasteur SA (France)

        • 14.1.1 Sanofi Pasteur SA (France) Company Profile

        • 14.1.2 Sanofi Pasteur SA (France) Recombinant Dna Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Hualan Biological Engineering Inc (China)

        • 14.2.1 Hualan Biological Engineering Inc (China) Company Profile

        • 14.2.2 Hualan Biological Engineering Inc (China) Recombinant Dna Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 MedImmune (US)

        • 14.3.1 MedImmune (US) Company Profile

        • 14.3.2 MedImmune (US) Recombinant Dna Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 SK Chemicals Co, Ltd (Korea)

        • 14.4.1 SK Chemicals Co, Ltd (Korea) Company Profile

        • 14.4.2 SK Chemicals Co, Ltd (Korea) Recombinant Dna Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 ALK - Abello A/S (Denmark)

        • 14.5.1 ALK - Abello A/S (Denmark) Company Profile

        • 14.5.2 ALK - Abello A/S (Denmark) Recombinant Dna Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer Inc (US)

        • 14.6.1 Pfizer Inc (US) Company Profile

        • 14.6.2 Pfizer Inc (US) Recombinant Dna Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BiondVax Pharmaceuticals Ltd (Israel)

        • 14.7.1 BiondVax Pharmaceuticals Ltd (Israel) Company Profile

        • 14.7.2 BiondVax Pharmaceuticals Ltd (Israel) Recombinant Dna Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck & Co, Inc (US)

        • 14.8.1 Merck & Co, Inc (US) Company Profile

        • 14.8.2 Merck & Co, Inc (US) Recombinant Dna Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Zydus Cadila (India)

        • 14.9.1 Zydus Cadila (India) Company Profile

        • 14.9.2 Zydus Cadila (India) Recombinant Dna Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Bharat Biotech International Limited (India)

        • 14.10.1 Bharat Biotech International Limited (India) Company Profile

        • 14.10.2 Bharat Biotech International Limited (India) Recombinant Dna Vaccines Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Janssen Pharmaceuticals, Inc (US)

        • 14.11.1 Janssen Pharmaceuticals, Inc (US) Company Profile

        • 14.11.2 Janssen Pharmaceuticals, Inc (US) Recombinant Dna Vaccines Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 GlaxoSmithKline Plc (UK)

        • 14.12.1 GlaxoSmithKline Plc (UK) Company Profile

        • 14.12.2 GlaxoSmithKline Plc (UK) Recombinant Dna Vaccines Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Takeda Pharmaceutical Company Limited (Japan)

        • 14.13.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile

        • 14.13.2 Takeda Pharmaceutical Company Limited (Japan) Recombinant Dna Vaccines Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Seqirus (UK)

        • 14.14.1 Seqirus (UK) Company Profile

        • 14.14.2 Seqirus (UK) Recombinant Dna Vaccines Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Altimmune, Inc (US)

        • 14.15.1 Altimmune, Inc (US) Company Profile

        • 14.15.2 Altimmune, Inc (US) Recombinant Dna Vaccines Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Dna Vaccines Industry Research Conclusions

    • 15.2 Recombinant Dna Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Dna Vaccines Industry Market Size (2018-2029)

    • Figure China Recombinant Dna Vaccines Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Recombinant Dna Vaccines Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Recombinant Dna Vaccines Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Recombinant Dna Vaccines Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Recombinant Dna Vaccines Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Recombinant Dna Vaccines Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Dna Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Dna Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Dna Vaccines Market Share by Type in 2018

    • Figure China Recombinant Dna Vaccines Market Share by Type in 2023

    • Figure China Recombinant Dna Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Dna Vaccines Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Recombinant Dna Vaccines Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Recombinant Dna Vaccines Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Recombinant Dna Vaccines Market Share by Application in 2018

    • Figure China Recombinant Dna Vaccines Market Share by Application in 2023

    • Figure China Recombinant Dna Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Dna Vaccines Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Recombinant Dna Vaccines Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Recombinant Dna Vaccines Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Recombinant Dna Vaccines Production Volume by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Dna Vaccines Production Volume Share by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Production Value by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Production Value Share by Region (2018-2023)

    • Figure China Recombinant Dna Vaccines Production Value Share by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Sales Volume by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Dna Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Sales Value by Region (2018-2023)

    • Table China Recombinant Dna Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Dna Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table North China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table North China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table Central China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table South China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table South China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table East China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table East China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Dna Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Dna Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Dna Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Dna Vaccines Sales Volume Share by Application (2018-2023)

    • Table Sanofi Pasteur SA (France) Company Profile

    • Table Sanofi Pasteur SA (France) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Hualan Biological Engineering Inc (China) Company Profile

    • Table Hualan Biological Engineering Inc (China) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table MedImmune (US) Company Profile

    • Table MedImmune (US) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table SK Chemicals Co, Ltd (Korea) Company Profile

    • Table SK Chemicals Co, Ltd (Korea) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table ALK - Abello A/S (Denmark) Company Profile

    • Table ALK - Abello A/S (Denmark) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc (US) Company Profile

    • Table Pfizer Inc (US) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table BiondVax Pharmaceuticals Ltd (Israel) Company Profile

    • Table BiondVax Pharmaceuticals Ltd (Israel) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc (US) Company Profile

    • Table Merck & Co, Inc (US) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Zydus Cadila (India) Company Profile

    • Table Zydus Cadila (India) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bharat Biotech International Limited (India) Company Profile

    • Table Bharat Biotech International Limited (India) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Janssen Pharmaceuticals, Inc (US) Company Profile

    • Table Janssen Pharmaceuticals, Inc (US) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc (UK) Company Profile

    • Table GlaxoSmithKline Plc (UK) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Limited (Japan) Company Profile

    • Table Takeda Pharmaceutical Company Limited (Japan) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Seqirus (UK) Company Profile

    • Table Seqirus (UK) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)

    • Table Altimmune, Inc (US) Company Profile

    • Table Altimmune, Inc (US) Recombinant Dna Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US